Evaluation of Usefulness of Contrast Enhanced MRI in Evaluation of Spine Trauma: Prospective Study

October 3, 2018 updated by: Guen Young Lee, Seoul National University Bundang Hospital

Non-contrast MRI with T2 fat suppression has been a useful imaging modality in evaluation spinal trauma.

However, the role of contrast enhancement has not investigated in patients with spinal trauma.

Therefore, this prospective study aims to evaluate the usefulness of contrast enhanced MRI for spinal trauma W/U clinically.

The study hypothesis is that there is no additional gain in addition of contrast enhanced study to routine non-contrast MRI.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

300

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Gyenggi-do
      • Seongnam-si, Gyenggi-do, Korea, Republic of, 463-707
        • Guen Young Lee
    • Gyeonggi-do
      • Seongnam-si, Gyeonggi-do, Korea, Republic of, 763-707
        • Seoul National University Bundang Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

300 patients that fulfilled the following criteria

Description

Inclusion Criteria:

  1. Patients who provided the informed consent
  2. Patients with spinal trauma
  3. Patients with age of 19 years or more

Exclusion Criteria:

  1. Relative contraindication of MR contrast

    • previous history of any adverse event after injection of magnetic resonance contrast
    • pregnant or breast-feeding state
    • within 2 weeks after liver transplantation
    • epileptic disorder
  2. Patients impossible with follow-up period of at least 2 months clinically
  3. Patients with severely impaired renal function of estimated glomerular filtration rate (GFR) < 30 mL/min/1.73m2 and/or on dialysis
  4. patients with age less than 19 years

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
ER-spine trauma
patients with spinal trauma, who initially visits in emergency room
non-contrast spine MRI(NC-MRI) contrast-enhanced spine MRI(CE-MRI)
Other Names:
  • non-contrast spine MRI(NC-MRI)
  • contrast-enhanced spine MRI(CE-MRI)
OUT-spine trauma
patients with spinal trauma, who initially visits in outpatient clinic
non-contrast spine MRI(NC-MRI) contrast-enhanced spine MRI(CE-MRI)
Other Names:
  • non-contrast spine MRI(NC-MRI)
  • contrast-enhanced spine MRI(CE-MRI)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The rate (%) of change of treatment option between non-surgery vs. surgery, after review of enhanced MRI finding, compared with non-enhanced MRI only
Time Frame: 2 months
The rate (%) of change of treatment option between non-surgery vs. surgery, after review of enhanced MRI finding, compared with non-enhanced MRI only
2 months
Confidence level
Time Frame: 2 months
Confidence level (1, definitely negative; 2, probably negative; 3, equivocal; 4, probably positive; 5, definitely positive) for lesion of spinal body, posterior compartment, soft tissue (posterior ligamentous complex of thoracolumbar spine and discoligamentous complex of cervical spine), spinal cord, and epidural/subdural hematoma/hemorrhage
2 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Diagnostic accuracy of non-enhanced and enhanced MRI
Time Frame: 2 months
Diagnostic accuracy of non-enhanced and enhanced MRI in patients with operations for each anatomical lesion (e.g. fracture of body, fracture of posterior compartment, soft tissue injury, cord injury, and epidural/subdural hematoma)
2 months
Inter- and intra-reader agreement of confidence level
Time Frame: 2 months
Inter- and intra-reader agreement of confidence level between non-enhanced and enhanced MRI
2 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prognostic value of enhanced MRI
Time Frame: 2 months
Prognostic value of enhanced MRI, compared with non-enhanced MRI, based on clinical feature during follow-up period: TLICS(thoracolumbar injury classification and severity score) or SLIC(subaxial cervical injury classification system)score for non-surgery group vs. surgery group
2 months
The rate (%) of change of treatment plan
Time Frame: 2 months
The rate (%) of change of treatment plan between posterior vs. anterior vs. anterior & posterior approaches, after review of enhanced MRI finding, compared with non-enhanced MRI only
2 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Guen Young Lee, MD, Seoul National University Bundang Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 24, 2013

Primary Completion (Actual)

December 14, 2016

Study Completion (Actual)

February 14, 2017

Study Registration Dates

First Submitted

June 14, 2013

First Submitted That Met QC Criteria

June 18, 2013

First Posted (Estimate)

June 19, 2013

Study Record Updates

Last Update Posted (Actual)

October 5, 2018

Last Update Submitted That Met QC Criteria

October 3, 2018

Last Verified

October 1, 2018

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • B-1304-199-003

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Trauma

Clinical Trials on NC-MRI, CE-MRI

Subscribe